GLP-3R is an investigational triple-hormone receptor agonist that simultaneously activates glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR). This triagonist profile is the subject of ongoing preclinical and clinical research examining synergistic receptor crosstalk effects not observed with single- or dual-agonist compounds. This research-grade lyophilized powder is synthesized under strict quality controls and accompanied by full analytical documentation. For Research Use Only. Not for human use.
Key Scientific Specifications
High-purity GLP-3R (≥98% by HPLC/MS, acetate salt form)
Verified 39-amino-acid sequence with lipidation and proprietary modifications for extended half-life
Lyophilized formulation for maximum long-term stability
Full Certificate of Analysis (COA) with HPLC, MS, amino acid analysis, and receptor-binding data
Manufactured in GMP-aligned, ISO-compliant facilities
Suitable for triple-agonist, energy balance, and hepatic lipid metabolism research models
Research-Referenced Attributes (Based on published preclinical and clinical literature; not therapeutic claims. For laboratory research use only.)
Triple receptor agonism (GLP-1R + GIPR + GCGR) synergistic receptor activation studied in preclinical models
Phase 2 clinical trial data examining body weight as a primary endpoint at 48 weeks (pubmed.ncbi.nlm.nih.gov)
Preclinical and observational data examining glycemic markers and hepatic lipid content in research models (pmc.ncbi.nlm.nih.gov)
Glucagon receptor activation pathways studied in relation to energy expenditure and lipid oxidation in animal models
Triglyceride and cardiometabolic marker data examined in controlled research settings
Applicable across metabolic dysfunction, hepatic steatosis, glycemic regulation, and cardiovascular outcome research models
Why Researchers Choose GLP-3R from Nationwide Peptides
Sequence verified against published literature (including lipidation profile)
High purity with receptor-binding fidelity confirmed by COA
Transparent analytical data (HPLC ≥98%, triple-receptor activity confirmed)
Suitable for academic, pharmaceutical, and metabolic-disease laboratory research
Competitive research pricing with bulk options
This product is for laboratory research use only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease or condition.